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Introduction
● Palliative Care services are often underutilized in 
patients with End-Stage Liver Disease (ESLD) and 
often only initiated at the end of life
● The Palliative Performance Score (PPS) is an 
important tool used in Palliative Care to assess 
functional status
● PPS has five functional dimensions: ambulation, 
activity level and evidence of disease, self-care, oral 
intake, and level of consciousness
● The aim of this study is to determine if there is a 
correlation between Model for End-Stage Liver 
Disease (MELD) score and PPS in ESLD patients
● MELD is used to predict mortality and to prioritize 
liver transplant allocation in ESLD patients
Methods
● A retrospective analysis was performed using a 
database of all the inpatient Palliative Care 
consults at our tertiary, urban liver transplant 
center from March 2006 to April 2015
● 294 of 4394 consults were for ESLD patients
● PPS from the Palliative Care consult and 
hospital length of stay were identified
● MELD-Na score was calculated from the day 
the consult was performed
● Patients with underlying liver malignancies and 
those without laboratory data for MELD-Na 
calculation were excluded 
Results
● 110 ESLD patients met our inclusion criteria
● Average MELD-Na of these patients was 30 (95% 
CI 28.1-31.8)
● Average PPS of these patients was found to be 
23.7% (95% CI 21.0-26.4)
● Patients were stratified by PPS and an average 
MELD-Na score was calculated for each PPS   
(Table 1)
● 46 of the 110 ESLD patients (41.8%) were found to 
have the lowest possible Palliative Performance 
Score of 10%
● Patients with a PPS of 10% were found to have an 
in-hospital mortality of 69.3%. All other patients 
with a PPS of 10% were discharged on hospice care
● The relationship between Palliative Performance 
Score and in-hospital mortality was also charted 
(Graph 1) 
Results
Discussion
● Analysis of this patient population showed that 
worsening PPS correlates with worsening 
MELD
● PPS may offer a complementary means of 
predicting mortality and evaluating transplant 
candidacy
● PPS may also help hepatologists to evaluate 
more objectively  the functional status of ESLD 
patients
● In the future, Palliative Care may play an 
increasingly important role in ESLD symptom 
management and transplant evaluation 
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Table 1.  Average MELD stratified by PPS.
Graph 1.  In-Hospital Mortality stratified by PPS.
N PPS MELD average
46 10% 31.6
16 20% 35.3
22 30% 28.8
15 40% 25.1
9 50% 23.6
2 60% 18.5
110 23.70% 30
